TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 135 filers reported holding TG THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $21,000 | +110.0% | 1,500 | +20.0% | 0.06% | +129.2% |
| Q4 2017 | $10,000 | -72.2% | 1,250 | -58.8% | 0.02% | -62.5% |
| Q3 2017 | $36,000 | +20.0% | 3,032 | 0.0% | 0.06% | +33.3% |
| Q2 2017 | $30,000 | -80.5% | 3,032 | -77.1% | 0.05% | -78.2% |
| Q1 2017 | $154,000 | +185.2% | 13,248 | +278.5% | 0.22% | +238.5% |
| Q1 2015 | $54,000 | -19.4% | 3,500 | -17.6% | 0.06% | -16.7% |
| Q4 2014 | $67,000 | +26.4% | 4,250 | -15.0% | 0.08% | +14.7% |
| Q3 2014 | $53,000 | +2550.0% | 5,000 | +1900.0% | 0.07% | +2166.7% |
| Q2 2014 | $2,000 | -50.0% | 250 | -50.0% | 0.00% | -57.1% |
| Q1 2014 | $4,000 | 0.0% | 500 | -50.0% | 0.01% | +16.7% |
| Q4 2013 | $4,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |